UBS Group’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-309,214
| Closed | -$31K | – | 7219 |
|
|
2016
Q3 | $31K | Buy |
309,214
+100,029
| +48% | +$10K | ﹤0.01% | 5035 |
|
|
2016
Q2 | $78K | Buy |
209,185
+86,906
| +71% | +$32.4K | ﹤0.01% | 4366 |
|
|
2016
Q1 | $47K | Buy |
122,279
+3,203
| +3% | +$1.23K | ﹤0.01% | 4766 |
|
|
2015
Q4 | $46K | Sell |
119,076
-17,108
| -13% | -$6.61K | ﹤0.01% | 4817 |
|
|
2015
Q3 | $78K | Sell |
136,184
-36,459
| -21% | -$20.9K | ﹤0.01% | 4386 |
|
|
2015
Q2 | $93K | Sell |
172,643
-32,852
| -16% | -$17.7K | ﹤0.01% | 4342 |
|
|
2015
Q1 | $168K | Sell |
205,495
-39,964
| -16% | -$32.7K | ﹤0.01% | 3893 |
|
|
2014
Q4 | $196K | Buy |
+245,459
| New | +$196K | ﹤0.01% | 3797 |
|